AMBALAL SARABHAI ENTERPRISES LTD. - 500009 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Pursuant to Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, we enclose herewith a confirmation certificate received from MCS Share Transfer Agent Limited, the Registrar and Transfer Agent of the Company for the period ended on 31st March, 2022. You are requested to take the above on record. AMBALAL SARABHAI ENTERPRISES LTD. - 500009 - Announcement Under Regulation 30 - Updates
We wish to inform you that CoSara Diagnostics Private Limited, a Joint Venture of a subsidiary of Ambalal Sarabhai Enterprises Limited and Co-Diagnostics, Inc, Salt Lake City, Utah, USA recently got permission to manufacture and sell its SARAQ(tm) Hepatitis C ("HCV") Viral Load Kit as an in vitro diagnostic ("IVD") from CDSCO. Please take on your record and oblige. AMBALAL SARABHAI ENTERPRISES LTD. - 500009 - Annual Disclosure Regarding Non-Applicability Of SEBI Circular SEBI/HO/DDHS/CIR/P/2018/144 Dated November 26, 2018 With Respect To Fund Raising By Issuance Of Debt Securities By Large Entity
Pursuant to the SEBI circular SEBV/HO/DDHS/CIR/P/2018/144 dated November 26, 2018 with respect to fund raising by issuance of Debt Securities by Large Entities, we wish to state that for the financial year ended March 31, 2022, the Company is not a 'Large Corporate' as per the framework and applicability criteria provided in the aforesaid Circular. Kindly take the same on record. AMBALAL SARABHAI ENTERPRISES LTD. - 500009 - Confirmation With Respect To Non-Applicability Of "Large Corporate Framework" Pursuant To Sebl Circular No. SEBI/HO/DDHS/CIR/P/2018/144 Dated 26Th November, 2018
With reference to aforesaid SEBI Circular with the subject matter of fund raising by issuance of debt securities by large entities, a listed entity that is fulfilling the criteria specified in such circular, shall consider "Large Corporate" (LC) and shall make disclosure on Stock Exchanges (SE). ln this connection, we submit that our Company is not a "Large Corporate" (LC) as prescribed under the aforesaid circular and as per our understanding the said framework is not applicable to our Company. Please take the above information on record. AMBALAL SARABHAI ENTERPRISES LTD. - 500009 - Statement Of Investor Complaints For The Quarter Ended March 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- DAMODAR H SEJPALDesignation :- Company Secretary and Compliance Officer AMBALAL SARABHAI ENTERPRISES LTD. - 500009 - Closure of Trading Window
This is to inform you that pursuant to the provisions of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, as amended from time to time, the trading window for the purpose of dealing in the equity shares of the Company shall remain closed from Friday, April 1, 2022 up to 48 hours after declaration of financial results for the quarter and year ended March 31, 2022. The date of meeting of the Board of Directors, to approve the financial results of the Company for the quarter and year ended March 31, 2022 will be informed in due course. AMBALAL SARABHAI ENTERPRISES LTD. - 500009 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) of SEBI (LODR) Regulations, 2015, we would like to inform you that the Registrar and Transfer Agent of the Company, MCS Share Transfer Agent Limited has received a request from the shareholder for issue of Duplicate Share Certificates as attached herewith. Please take on your record and oblige. AMBALAL SARABHAI ENTERPRISES LTD. - 500009 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) of SEBI (LODR) Regulations, 2015, we would like to inform you that the Registrar and Transfer Agent of the Company, MCS Share Transfer Agent Limited has received below mentioned request from the shareholder for issue of Duplicate Share Certificates. Please take on your record and oblige. AMBALAL SARABHAI ENTERPRISES LTD. - 500009 - Submission Of Udins For Limited Review Reports For The Quarter And Nine Months Ended December 31,2021
In continuation of the outcome of the Board meeting and Financial Result (Standalone & Consolidated) for the Quarter and Nine Months ended 31.12.2021 along with Limited Review Report(s) submitted to your good office vide Ack. No. 3727270 & 3727299 respectively dated 14.02.2022 (uploaded time: 3:06 p.m. & 3:11 p.m. respectively), We would further like to submit generated UDIN(s) and mentioned in the Limited Review Reports issued by the Statutory Auditors of the Company. Except this there is no other changes in Limited Review Report(s) filed earlier with your good office. Please find enclosed the Limited Review Report(s) along with UDIN(s). You are requested to take the same on your record. AMBALAL SARABHAI ENTERPRISES LTD. - 500009 - Board Meeting Outcome for Outcome Of The Board Meeting Held On 14.02.2022
Pursuant to Regulations 30 & 33 of Chapter IV read with Schedule III of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, we are pleased to inform you that the Board of Directors of the Company in their meeting held on 14th February, 2022, has considered, approved and taken on record the Unaudited Financial Results (Standalone & Consolidated) of the Company for the Quarter and Nine months ended on 31st December,2021 along with Limited Review Report by Auditors thereon. In this regard, please find enclosed herewith the following: A. Unaudited Financial Results (Standalone & Consolidated) of the Company for the Quarter and Nine months ended on 31st December,2021; and B. Limited Review Report issued by the Statutory Auditors of the Company.